Davidson Kempner Capital Management’s Starling Oncology, Inc. Warrant STLNW Stock Holding History
Bought
Maintained
Sold
Other funds holding STLNW
OMC
LP
DM
WAM
AGM
TCM
CS
Davidson Kempner Capital Management's STLNW Position: Q1 2026 in Review
Davidson Kempner Capital Management held its Starling Oncology, Inc. Warrant (STLNW) position steady in Q1 2026 at 318,710 shares worth $17.7K. The position accounts for ﹤0.01% of the portfolio, ranked #205.
Davidson Kempner Capital Management first reported a position in STLNW in Q1 2021 and has held it in 21 quarters since. The position peaked at $551K in Q2 2021. 11 funds tracked by Wall St. Rank hold STLNW as of Q1 2026.
- Davidson Kempner Capital Management held 318,710 shares of Starling Oncology, Inc. Warrant worth $17.7K as of Q1 2026.
- Davidson Kempner Capital Management left its Starling Oncology, Inc. Warrant share count unchanged in Q1 2026.
- Starling Oncology, Inc. Warrant made up ﹤0.01% of Davidson Kempner Capital Management's portfolio in Q1 2026, its #205 holding.
- Davidson Kempner Capital Management first reported a position in Starling Oncology, Inc. Warrant in Q1 2021 and has held it in 21 quarters since.
- Davidson Kempner Capital Management's Starling Oncology, Inc. Warrant position peaked at $551K in Q2 2021.
- 11 funds tracked by Wall St. Rank held Starling Oncology, Inc. Warrant as of Q1 2026.
Based on Davidson Kempner Capital Management's 13F filing for Q1 2026, filed 15 May 2026.